This week, several experts involved in the ASFaVIP Project met in Berlin to advance ongoing work related to ASF vaccine licensing pathways.
The meeting brought together specialists from different disciplines to:
– align on regulatory considerations and requirements
– discuss key scientific and safety aspects supporting future licensing
– coordinate next steps towards building a comprehensive and robust dossier
👉 These exchanges are essential to ensure that future ASF vaccination strategies are supported by solid scientific evidence and aligned with regulatory expectations.
Such collaborative efforts highlight the importance of cross-sector dialogue in addressing complex challenges in animal health.
